Nikhita Kathuria-Prakash

Optimal Thyroid Hormone Replacement Dose in Immune Checkpoint Inhibitor-Associated Hypothyroidism is Distinct from Hashimoto's Thyroiditis.

A. Drakaki, T. Angell, N. Kathuria-Prakash, 2022, Thyroid : official journal of the American Thyroid Association.

The Potential Revolution of Cancer Treatment with CRISPR Technology

A. Pantuck, Melissa L. Abel, Alexander W. Sun, 2023, Cancers.

ALK Inhibition With Alectinib for Refractory Metastatic Renal Cell Carcinoma With ALK Rearrangement: A Rare Case Report and Literature Review

A. Pantuck, Alexandra Drakaki, Huihui Ye, 2024, JCO Precision Oncology.

MicroRNAs in Genitourinary Malignancies: An Exciting Frontier of Cancer Diagnostics and Therapeutics

Alexandra Drakaki, Nikhita Kathuria-Prakash, Pranali Dave, 2024, International journal of molecular sciences.

Risk of severe immune-related adverse events in cancer patients with pre-existing autoimmunity receiving immune checkpoint inhibitor therapy

Alexandra Drakaki, Nikhita Kathuria-Prakash, Melissa G. Lechner, 2024, Current Cancer Reports.

Multicenter Safety and Practice for Off-Label Diagnostic Use of Ferumoxytol in MRI.

J. Finn, M. Fogel, A. Radjenovic, 2019, Radiology.

Factors Associated With Hospitalization Among Breast Cancer Patients With COVID-19: A Diverse Multi-Center Los Angeles Cohort Study

Nicholas Hornstein, Alexander W. Sun, N. Kathuria-Prakash, 2021, Clinical Breast Cancer.